Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>Products>This Product


Product Image
Product Description

HardyCHROM™ MRSA, (methicillin resistant Staphylococcus aureus), 15x100mm plate, order by the package of 10, by Hardy Diagnostics

HardyCHROM™ MRSA is a selective and differential culture medium that facilitates the isolation and identification of methicillin resistant Staphylococcus aureus (MRSA).
This new chromogenic medium simplifies the identification of MRSA infections. MRSA strains grown in the presence of chromogenic substrates produce deep pink to magenta colonies.
Selective agents will inhibit non-MRSA strains. Additional ingredients have been added to increase the sensitivity and specificity of the medium by inhibiting gram-negative organisms, yeast, and most other gram-positive cocci.hardychrommrsa_product.gif

•    Distinct color change read-out
•    Bright color development
•    Economically priced to save you money!
•    Read-out at 24 hours
This media is to be stored and incubated in the dark. If you have a light in your refrigerator, incubator, or you leave the media exposed to light on the bench top, Hardy Diagnostics offers free Blok-Boxes. Blok-Box is a reusable cardboard box that hold one PK10 of media plates.

Product HardyCHROM™ MRSA
Company Hardy Diagnostics
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Hardy Diagnostics
1430 West McCoy Lane, Santa Maria, CA 93455

Tel: +1 805-346-2766
Fax: +1 805-346-2760

Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
MRIs for Fetal Health
Algorithm could help analyze fetal scans to determine whether interventions are warranted.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Supercomputers Could Improve Cancer Diagnostics
Researchers push the boundaries of cancer research through high-performance computing to map the human immunone.
Transgenomic, Precipio Diagnostics Merger
Merger will creates a robust diagnostic platform focused on improving accuracy of cancer diagnoses.
Inflammation Test May Predict Cardiovascular Disease
An assessment combining measures of immune-cell responsiveness predicted cardiovascular problems in individuals who likely would have slipped under the radar.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Potential Urine Test for CJD
Researchers at the Medical Research Council (MRC) Prion Unit at UCL have found that it may be possible to determine whether or not a person has sporadic Creutzfeldt-Jakob Disease (sCJD) by testing their urine for the presence of abnormal prion proteins.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos